-
Je něco špatně v tomto záznamu ?
Effects of sanguinarine and chelerythrine on the cell cycle and apoptosis
J. Malikova, A. Zdarilova, A. Hlobilkova
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
NLK
Directory of Open Access Journals
od 2001
Free Medical Journals
od 1998
ROAD: Directory of Open Access Scholarly Resources
od 2001
PubMed
16936897
DOI
10.5507/bp.2006.001
Knihovny.cz E-zdroje
- MeSH
- alkaloidy farmakologie MeSH
- apoptóza účinky léků MeSH
- benzofenantridiny farmakologie MeSH
- buněčné linie MeSH
- buněčný cyklus účinky léků MeSH
- isochinoliny farmakologie MeSH
- lidé MeSH
- protinádorové látky farmakologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
OBJECTIVES: This review summarizes the involvement of sanguinarine and chelerythrine in cell cycle regulation and cell death in various cell lines. It is focused on their potential in the treatment of cancer. METHODS: We conducted a search of PubMed, ScienceDirect and Medline for papers on the molecular mechanisms of the biological activity of sanguinarine and chelerythrine published mainly from 1995 to 2006. RESULTS AND CONCLUSIONS: Our analysis of the published studies suggested that these alkaloids are not only good candidates for chemotherapeutic regimens but may also contribute to the development of successful immune therapies of some carcinomas due to their apoptotic potential. However, the complete signalling cascade in which sanguinarine and chelerythrine treatment induces apoptotic cell death is not yet understood. Overall, the results of recent studies suggest that sanguinarine and chelerythrine may be useful as agents in the management of cancer.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13003705
- 003
- CZ-PrNML
- 005
- 20130212112048.0
- 007
- ta
- 008
- 130128s2006 xr df f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2006.001 $2 doi
- 035 __
- $a (PubMed)16936897
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Steigerová, Jana, $d 1979- $7 xx0142054 $u Laboratory of Molecular Pathology and Institute of Pathology, Faculty of Medicine, Palacký University, Olomouc
- 245 10
- $a Effects of sanguinarine and chelerythrine on the cell cycle and apoptosis / $c J. Malikova, A. Zdarilova, A. Hlobilkova
- 520 9_
- $a OBJECTIVES: This review summarizes the involvement of sanguinarine and chelerythrine in cell cycle regulation and cell death in various cell lines. It is focused on their potential in the treatment of cancer. METHODS: We conducted a search of PubMed, ScienceDirect and Medline for papers on the molecular mechanisms of the biological activity of sanguinarine and chelerythrine published mainly from 1995 to 2006. RESULTS AND CONCLUSIONS: Our analysis of the published studies suggested that these alkaloids are not only good candidates for chemotherapeutic regimens but may also contribute to the development of successful immune therapies of some carcinomas due to their apoptotic potential. However, the complete signalling cascade in which sanguinarine and chelerythrine treatment induces apoptotic cell death is not yet understood. Overall, the results of recent studies suggest that sanguinarine and chelerythrine may be useful as agents in the management of cancer.
- 650 _2
- $a alkaloidy $x farmakologie $7 D000470
- 650 _2
- $a protinádorové látky $x farmakologie $7 D000970
- 650 _2
- $a apoptóza $x účinky léků $7 D017209
- 650 _2
- $a benzofenantridiny $x farmakologie $7 D053119
- 650 _2
- $a buněčný cyklus $x účinky léků $7 D002453
- 650 _2
- $a buněčné linie $7 D002460
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a isochinoliny $x farmakologie $7 D007546
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Galandáková, Adéla, $d 1979- $7 stk2008428623 $u Institute of Medical Chemistry and Biochemistry, Faculty of Medicine, Palacký University, Olomouc
- 700 1_
- $a Hlobilková, Alice, $d 1972- $7 xx0019008 $u Laboratory of Molecular Pathology and Institute of Pathology, Faculty of Medicine, Palacký University, Olomouc
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic $x 1213-8118 $g Roč. 150, č. 1 (2006), s. 5-12
- 910 __
- $a ABA008 $b A 1502 $c sign $y 3 $z 0
- 990 __
- $a 20130128 $b ABA008
- 991 __
- $a 20130212112230 $b ABA008
- 999 __
- $a ok $b bmc $g 966361 $s 801900
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2006 $b 150 $c 1 $d 5-12 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- LZP __
- $b NLK111 $a Pubmed-20130128